IMPROVING THE QUALITY OF LIFE IN PSORIASIS PATIENT THROUGH HEALTH PROMOTION APPROACH AT HAJI ADAM MALIK GENERAL HOSPITAL, MEDAN, INDONESIA
DOI:
https://doi.org/10.22159/ajpcr.2018.v11i10.27160Keywords:
Quality of life, Psoriasis, Dermatology life quality index, Health promotionAbstract
Objective: Psoriasis is a chronic inflammatory skin disease, can affect all ages characterized by reddish plaques that are covered by thick scales of silvery white and firmly bounded. Psoriasis is a skin disease that is difficult to cure because psoriasis can interfere with life quality of life behavior even cause the level of stress for the patient. This study aims to evaluate the effect of health promotion of quality of life of psoriasis patients.
Methods: This research is an experiment between pre- and post-test that aims to know the effort of improving the quality of life of psoriasis patient through a health promotion approach. Population in this research is patient of psoriasis in the draft of human rights number 60 people. Then, divide the questioner to the respondents who made twice before the health promotion and after health promotion in the experimental group.
Result: The study showed significant differences between pre- and post-test values for quality of life, stress level, and behavior toward health promotion. Data analysis with paired t-test at 95% confidence level, quality of life with lecture method (p=0.001), quality of life (p=0.001), and behavior with method of Booklet (p=0.001).
Conclusion: It is recommended for health workers more often to provide health promotion because psoriasis is chronic and recidive disease, it is necessary to improve the quality of service in hospitals by providing education in the form of health promotion in patients not to quickly despair and can comply with doctor's advice.
Downloads
References
Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Fitzpatrick’s Dermatology in General Medicine 8th edition. New York: McGraw-Hill; 2008.
Krueger JG. The immunologic basis for the treatment of psoriasis with new biologic agents. J Am Acad Dermatol 2002;46(1):19-23.
Feldman S, Krueger G. Psoriasis assessment tools in clinical trial. Ann Rheum Dis 2005;64: 65-8.
Basko P, Juliana L, Petronic-RV. Psoriasis: epidemiology, natural history, and differential diagnosis. Psoriasis: Targets and Therapy 2012;2(1):67-76.
Smith CH, Anstey AV, Baker JN, Burden AD, Chalmers RJ, et al. British association of dermatologist guidelines for use of biological interventions in psoriasis 2005. Br J Dermatol 2005;153(3):486-87.
Orgaz MJ, Buendia EA, Arrabol PMA, Ruiz JC, Arias SS. Deficiency of serum concentration of 25-hydroxyvitamin D in psoriatic patient: a case-control study. J Am Acad Dermatol 2012; 67(5):931-08.
Dogra S, Yadav S. Psoriasis in India: prevalence and pattern. Indian J Dermatol Venereol Leprol 2010;76(2):595-600.
Brezinski EA, Follansbee MR, Armstrong EJ, Armstrong AW. Endothelial dysfunction and the effects of TNF inhibitors on the endothelium in psoriasis and psoriatic arthritis: a systematic review. Curr Pharm Des 2014;20(2):513-28.
Diluvio L, Vollmer S, Besgen P, Ellwart JW, Chimenti S, Prinz JC. Identical TCR beta-chain rearrangements in streptococcal angina and skin lesions of patients with psoriasis vulgaris. J. Immunol 2006;176(2):7104-11.
Hamada IR, Al Raddadi AA, Bahamdan KA, Fatanil MI, Al Rakban AM, et al. Saudi practical guidelines on biological treatment of psoriasis. J Dermatolog Treat 2015;26(3):223-9.
Coates LC, Kavanaugh A, Mease PJ, Soriano ER, Laura AF, Armstrong AW, et al. Group research and assessment of psoriasis and psoriatic arthritis 2015 treatment recommendations for psoriatic arthritis. Arthritis Rheumatol 2016;69(5):1060-71.
Yang HJ, Yang KC. Impact of psoriasis on quality of life in Taiwan. Dermatologica Sinica 2015;33(1):146-50.
Garcia EM, Santiago SA, Salas VI, Colmenero CG, Mellado VG, Eisman AB. Quality of life in person living with psoriasis patients. J Am Acad Dermatol 2014;7(2):1-6.
Fortune DG, Richards HL, Griffiths CEM. Psychological factors in psoriasis: consequences, mechanism, and interventions. Dermatol Clin 2005;23(1):681-94.
Bradford NK, Chan RJ. Health promotion and psychological interventions for adolescent and young adult cancer survivors: A systematic literature review. Cancer Treatment Reviews 2017;55(1):57-70.
Sholiman GM, Osman SK, Hamdan AM. Preparation and evaluation of anthralin biodegradable nanoparticles as a potential delivery system for the treatment of psoriasis. Int J Pahrm Pharm Sci 2015;7(12):36-40.
Gizawa SE, Fadel M, Mourad B, Elnaby FEZ. Betamethasone dipropionate gel for treatment of localized plaque psoriasis. Int J Pharm Pharm Sci 2018;9(8):173-82.
Abdelgawad R, Nasr M, Hamza MY, Awad GAS. Topical and systemic dermal carriers for psoriasis. Int J Curr Pharm Res 2016;8(1):4-9.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
